Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment | Taiwan News
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment | 2022-02-28 15:00:00
Source: taiwannews.com.tw
Page 3 - Science Driven News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Science Driven. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Science Driven Today - Breaking & Trending Today
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
Press release content from Accesswire. The AP news staff was not involved in its creation.
Source: apnews.com
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
Heidelberg Pharma AG / Key word(s): AllianceHeidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment27-Feb-2022 / 13:11 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is...
Source: pharmiweb.com
AKSO and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize AB002 in Asi
- Huadong Medicine is granted from AKSO Biopharmaceutical an exclusive right to develop and commercialize AB002 in the Asia Pacific Ex-Japan region for solid tumors; AKSO Biopharmaceutical to receive up to 75 million USD upfront, R&D funding, potential regulatory and commercial milestone payments- Strategic partners...
Source: pharmiweb.com
AKSO Biopharmaceutical, Inc.: AKSO and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize AB002 in Asia Pacific Ex-Japan
Huadong Medicine is granted from AKSO Biopharmaceutical an exclusive right to develop and commercialize AB002 in the Asia Pacific Ex-Japan region for solid tumors; AKSO Biopharmaceutical to receive up
Source: finanznachrichten.de